[Late onset of heparin-induced thrombocytopenia with recurrent arterial thromboses and amputation].
METHODS
An 80-year-old woman had been hospitalized in a psychiatric clinic where, on the 22nd day, she sustained a fracture of the neck of the left femur, which was treated by internal screw fixation. The postoperative course was at first without complication. But 9 days postoperatively her platelet count had fallen to 59,000/microliter. As heparin induced type II thrombocytopenia (HIT II) was suspected, the thrombosis prophylaxis with low-molecular heparin was replaced by sodium danaparoid (twice 750 units subcutaneously). Despite this, ischaemia of the right lower leg developed and required amputation. On the following day the left lower leg and foot also became ischemic, where upon she was admitted to the author's hospital (37 days after her admission to the psychiatric clinic).


METHODS
The patient was in a reduced general condition (body-mass index 19.5 kg/m2). She was disoriented as to place and time. Her blood pressure was 140/80 mmHg, her pulse irregular with a ventricular rate of 100/min. The skin below the middle of the left lower leg was cold and livid and the pedal pulses were not palpable.


METHODS
Haemoglobin content was 9.7 g/dl, the white cell count 9,200/microliter, and platelet count 54,000/microliter. Electrolytes and creatinine were within normal limits.


METHODS
Thrombendarterectomy was performed once via the left groin under danaparoid anticoagulation. There was no re-occlusion and the patient was able to walk again.--It was ascertained subsequently, she had already been given ordinary heparin in the psychiatric clinic for 20 days. Her platelet count of around 70,000/microliter returned to normal even though heparin administration was continued.


CONCLUSIONS
A reduction in platelet count by more than half during heparin treatment suggests heparin-induced thrombocytopenia, in which case heparin should be discontinued at once. In high-risk patients adequate treatment should be initiated with other anticoagulants even before the occurrence of thromboembolism.
Mörsdorf
S
S
Abteilung für klinische Hämostaseologie und Transfusionsmedizin, Universitätskliniken des Saarlandes. S.moersdorf@med-rz.uni-Sb.de
Pistorius
G
G
Orthleb
R
R
Pindur
G
G
Schenk
J
J
D000368:Aged; D000369:Aged, 80 and over; D000671:Amputation, Surgical; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000627:therapeutic use; D004338:Drug Combinations; D004691:Endarterectomy; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006496:Heparinoids / Q000627:therapeutic use; D006497:Heparan Sulfate / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000209:etiology* / Q000628:therapy; D007866:Leg / Q000098:blood supply* / Q000601:surgery; D012008:Recurrence; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D013923:Thromboembolism / Q000209:etiology* / Q000628:therapy; D013927:Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid
Später Beginn einer Heparin-induzierten Thrombozytopenie mit rezidivierenden arteriellen Thrombosen und Amputation.